n-3 polyunsaturated fatty acids in milk is associate to weight gain and growth in premature infants

Table 4 Regression coefficient (β) and p-value of the variables included in the regression model for BMI (kg/m2)

Fatty acids	Difference of fatty acids		Time* (months)	Difference of fatty acids*time
	β	p	β	β	P
Total *trans* ^a	-0.45	0.42	0.68	0.002	0.99
Total saturated ^b	0.48	0.38	0.51	0.13	0.27
C18:1 n-9 (Oleic)	0.13	0.81	0.81	-0.09	0.45
C18:3 n-3 (α-Linolenic)	0.96	0.08	0.77	-0.05	0.64
C18:2 n-6 (Linoleic)	0.21	0.72	1.12	-0.28	0.02
Total essentials ^c	0.21	0.72	1.12	-0.28	0.02
C20:5 n-3 (EPA)	-0.34	0.54	0.54	0.10	0.40
C22:6 n-3 (DHA)	0.76	0.18	1.01	-0.22	0.05
C20:4 n-6 (ARA)	0.16	0.78	0.98	-0.19	0.09
Total LC-PUFA ^d	0.80	0.15	1.09	-0.28	0.01
Total n-3 PUFA ^e	1.06	0.05	0.82	-0.09	0.43
Total n-6 PUFA ^f	0.04	0.94	0.93	-0.16	0.17

*P-values < 0.03 for all fatty acids. ^aIncludes all of isomers of C18:1; ^bincludes C14:0, C15:0, C16:0 and C18:0; ^cincludes C18:3 n-3 and C18:2 n-6; ^dincludes EPA (eicosapentaenoic fatty acid), DHA (docosahexaenoic fatty acid) and ARA (arachidonic fatty acid); ^eincludes C18:3 n-3, C20:5 n-3, C22:5 n-3 and C22:6 n-3; ^fincludes C18:2 n-6, C18:3 n-6, C20:2 n-6, C20:3 n-6, C20:4 n-6 and C22:4 n-6. PUFA, polyunsaturated fatty acid.

ISSN: 1476-511X